Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Byrd

Showing results (61-70 of 188) with videos related to

Pageof 19
Sort By:
Journal of General Internal Medicine|May 1, 1996
Physician extenders for cost-effective management of hypercholesterolemiaG Schectman, N Wolff, J C Byrd, et al.
Journal of General Internal Medicine|May 1, 1990
The 35-mm slide--is blue better?G R Heudebert, J Van Ruiswyk, J C Byrd, et al.
Cancer Research|November 1, 1987
Characterization of quantitative mucin variants from a human colon cancer cell lineS F Kuan, J C Byrd, C B Basbaum, et al.
Seminars in Oncology|March 3, 1998
Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goalsJ C Byrd, K R Rai, E A Sausville, et al.
The Journal of Biological Chemistry|August 30, 2000
Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligandsN Mazurek, J Conklin, J C Byrd, et al.
Seminars in Oncology|October 26, 2000
Novel therapies for chronic lymphocytic leukemia in the 21st centuryJ C Byrd, J K Waselenko, M Keating, et al.
Leukemia & Lymphoma|March 1, 1996
Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemiaJ C Byrd, W J Edenfield, N S Dow, et al.
Leukemia|February 16, 2012
XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cellsS Rafiq, C Cheney, X Mo, et al.
International Journal of Cancer|January 2, 1992
Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitroY Niv, J C Byrd, S B Ho, et al.
Cancer|August 15, 1997
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous systemR S Bresalier, P S Yan, J C Byrd, et al.
Pageof 19

Showing results (61-70 of 188) with videos related to

Sort By:
Pageof 19
Journal of General Internal Medicine|May 1, 1996
Physician extenders for cost-effective management of hypercholesterolemiaG Schectman, N Wolff, J C Byrd, et al.
Journal of General Internal Medicine|May 1, 1990
The 35-mm slide--is blue better?G R Heudebert, J Van Ruiswyk, J C Byrd, et al.
Cancer Research|November 1, 1987
Characterization of quantitative mucin variants from a human colon cancer cell lineS F Kuan, J C Byrd, C B Basbaum, et al.
Seminars in Oncology|March 3, 1998
Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goalsJ C Byrd, K R Rai, E A Sausville, et al.
The Journal of Biological Chemistry|August 30, 2000
Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligandsN Mazurek, J Conklin, J C Byrd, et al.
Seminars in Oncology|October 26, 2000
Novel therapies for chronic lymphocytic leukemia in the 21st centuryJ C Byrd, J K Waselenko, M Keating, et al.
Leukemia & Lymphoma|March 1, 1996
Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemiaJ C Byrd, W J Edenfield, N S Dow, et al.
Leukemia|February 16, 2012
XmAb-5574 antibody demonstrates superior antibody-dependent cellular cytotoxicity as compared with CD52- and CD20-targeted antibodies in adult acute lymphoblastic leukemia cellsS Rafiq, C Cheney, X Mo, et al.
International Journal of Cancer|January 2, 1992
Mucin synthesis and secretion in relation to spontaneous differentiation of colon cancer cells in vitroY Niv, J C Byrd, S B Ho, et al.
Cancer|August 15, 1997
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous systemR S Bresalier, P S Yan, J C Byrd, et al.
Pageof 19